DOH allots P18-M for trials of flu drug Avigan as COVID-19 treatment
The Department of Health (DOH)
has set aside P18 million for the clinical trials of Japanese anti-influenza drug Avigan as a potential treatment for the new coronavirus disease, President Duterte said Monday (May 18).
Around 80 to 100 patients
are expected to undergo the clinical research for the use of Avigan in the country, the President said in his eighth weekly report to Congress on the government’s coronavirus response.
“The DOH, through its Advancing Health through Evidence-Assisted Decisions with Health Policy and Systems Research, has allocated P18 million for Avigan trials,” Duterte said.
“As of 11 May 2020,
there are three identified sites for Avigan trials with a target of 80 to100 subject patients,” he added.
Also, the President said 24 hospitals will participate in the “Solidarity Trials” initiated by the World Health Organization to search for a coronavirus treatment.
Twelve hospitals are already actively recruiting participants.
So far, Duterte said there are 87 participants or enrollees in the clinical trials
The government is also exploring involvement in other clinical studies for the coronavirus treatment.
Manila Bulletin News
COVID-19 cases in PH climbs to 13,221 » Manila Bulletin News
https://news.mb.com.ph/2020/05/20/covid-19-cases-in-ph-climbs-to-13221/
PH virus patients to be given Avigan | Inquirer News
The government is also exploring involvement in other clinical studies for the coronavirus treatment.
Manila Bulletin News
COVID-19 cases in PH climbs to 13,221 » Manila Bulletin News
https://news.mb.com.ph/2020/05/20/covid-19-cases-in-ph-climbs-to-13221/
PH virus patients to be given Avigan | Inquirer News